Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000485600 | SCV000568835 | uncertain significance | not provided | 2017-12-06 | criteria provided, single submitter | clinical testing | The R530X variant of uncertain significance in the MIB1 gene has been previously reported in one Southern European individual diagnosed with LVNC and was shown to segregate with disease in five additional affected relatives (Luxán et al., 2013). Using blood samples from affected relatives harboring R530X, Luxán et al. (2013) demonstrated that mutant mRNA expression is almost completely abolished and truncated MIB1 protein is not detectable, suggesting that R530X causes loss of protein expression through nonsense-mediated mRNA decay. Blood samples from these affected carriers also showed reduced NOTCH1 activity and target-gene expression (Luxán et al., 2013). In addition, the R530X variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). Nevertheless, only four other variants in the MIB1 gene have been reported in HGMD in association with MIB1-related disorders, and no other truncating variants in the MIB1 gene have been reported in association with cardiomyopathy (Stenson et al., 2014). Thus, the mechanism of disease for variants in the MIB1 gene remains to be definitely established. Identification of the R530X variant in additional affected individuals, larger segregation studies, and further functional evidence are necessary to further clarify the role of this variant in disease.Therefore, additional evidence is needed to determine whether this variant is pathogenic or benign. |
Genome Diagnostics Laboratory, |
RCV000033170 | SCV000743478 | likely pathogenic | Left ventricular noncompaction 7 | 2016-11-17 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000033170 | SCV004041497 | likely pathogenic | Left ventricular noncompaction 7 | 2023-03-08 | criteria provided, single submitter | clinical testing | |
Petrovsky National Research Centre of Surgery, |
RCV000033170 | SCV005061574 | likely pathogenic | Left ventricular noncompaction 7 | 2024-05-20 | criteria provided, single submitter | clinical testing | We observed a heterozygous NM_020774.4:c.1588C>T (p.Arg530*) genetic variant in the MIB1 gene on WES data in a sporadic case of Sudden Unexplained Nocturnal Death Syndrome (SUNDS) in 15 y.o. male adolescent. The c.1588C>T (p.Arg530*) genetic variant is in The Genome Aggregation Database (gnomAD) v2.1.1 and v4.1.0 with total MAF 0.00004598 and 0.00003965 respectively (Date of access 18-06-2023). ClinVar contains an entry for this variant (Variation ID: 40092). This variant leads to NMD of the mutant transcript according to in silico predictors and Luxán et al. (2013) experimental data (PMID: 23314057). Based on these evidences, we consider it to classify this variant as Likely Pathogenic. |
OMIM | RCV000033170 | SCV000056952 | pathogenic | Left ventricular noncompaction 7 | 2013-02-01 | no assertion criteria provided | literature only | |
Diagnostic Laboratory, |
RCV000485600 | SCV001742100 | likely pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000485600 | SCV001920358 | likely pathogenic | not provided | no assertion criteria provided | clinical testing |